Detalles de la búsqueda
1.
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT-FET cycles.
Reprod Med Biol
; 22(1): e12511, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36969958
2.
A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology.
Reprod Med Biol
; 21(1): e12424, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34938148
3.
Different anti-Mullerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes.
Reprod Med Biol
; 18(3): 263-272, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312105
Resultados
1 -
3
de 3
1
Próxima >
>>